Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes
European Patent
02773789.9
Filed on 2000-10-16
02773789.9
Filed on 2000-10-16
Broadly Cross-Reactive Neutralizing Antibodies Against Human Immunodeficiency Virus selected By ENV-CD4-CO-Receptor Complexes
Australia
2002337885
Filed on 2002-10-16
2002337885
Filed on 2002-10-16
Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells.
Canada
2461351
Filed on 2002-09-25
2461351
Filed on 2002-09-25
Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells.
Australia
2002327053
Filed on 2002-09-25
2002327053
Filed on 2002-09-25
Mutated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells.
European Patent
02761818.0
Filed on 2002-09-25
02761818.0
Filed on 2002-09-25
Mutuated Anti-CD22 Antibodies with Increased Affinity To CD22 Expressing Leukemia Cells.
US Patent 7,355,012
Filed on 2004-03-23
Filed on 2004-03-23
Hypoxia-Inducible Factor 1alpha Variants and Methods of Use
US Patent 7,193,053
Filed on 2004-04-23
Filed on 2004-04-23
Use Of Smad3 Inhibitor In The Treatment Of Fibrosis Dependent On Epithelial To Mesenchymal Transition As In The Eye And Kidney
Patent Cooperation Treaty
PCT/US2004/03563
Filed on 2004-01-16
PCT/US2004/03563
Filed on 2004-01-16
NUCLEOTIDE AND DEDUCED AMINO ACID SEQUENCES OF TUMOR GENE, INT6,
US Patent 7,067,635
Filed on 2004-02-19
Filed on 2004-02-19
Fitness Assay and Associated Methods
Australia
2004200629
Filed on 2004-02-18
2004200629
Filed on 2004-02-18